Liquid blood test for mature B-cell tumors
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at how a “liquid biopsy,” a test done on blood, may help in people with mature B-cell tumors. It mainly checks whether you can take part and complete the planned study procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult age 18 or older.
- You have a confirmed diagnosis of a mature B-cell tumor.
- Your diagnosis matches the World Health Organization (WHO) 2008 criteria.
- You’re willing and able to follow the study’s scheduled visits and procedures.
- You have signed informed consent (you agree to join after learning about the study).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a blood test (liquid biopsy) can help doctors better understand your lung cancer and plan your treatment. You'll have a blood sample taken alongside standard biopsies to see if the blood test provides useful information about your cancer.
This study looks at “cell-free DNA,” meaning tiny bits of DNA found in blood, in people with mature B-cell lymphoma. It may help doctors understand the disease better and how blood tests could be used to monitor it.
This study collects blood and may also use existing tumor tissue to help develop a liquid biopsy blood test for people with solid (non-blood) cancers. You may qualify if you have a current cancer with tumor in the body and can provide blood samples at set visits.
This trial studies “liquid biopsies,” which are blood tests, to help learn about specific cancers in children. It may help doctors monitor cancer and guide treatment using less invasive tests.
This study uses a simple blood test to look at the genetic makeup of your tumor. The results may help your doctors choose the best treatment for you. You will need to provide a tumor sample or have a biopsy.
This study looks at whether a simple blood test (called liquid biopsy) can help monitor how well your cancer treatment is working. By checking for tumor DNA in your blood before and during treatment, researchers hope to see if the treatment is effective and if the cancer is responding, which could help guide your care.
Hear when a new Mature B-Cell Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.